Coronary vascular endothelium, a common target in patients with diabetes mellitus, cigarette smoking, hypercholesterolaemia, hypertension and menopausal status

Nephrology Dialysis Transplantation

Volumn 13, Issue SUPPL. 4, 1998, Pages 16-19

  Nitenberg, Alain ^a   Antony, Isabelle ^a  

^a HÔPITAL LOUIS MOURIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; CHOLESTEROL; ENDOTHELIUM DERIVED RELAXING FACTOR; ISOSORBIDE DINITRATE;

ANGIOCARDIOGRAPHY; BLOOD FLOW VELOCITY; CIGARETTE SMOKING; COLD PRESSOR TEST; CONFERENCE PAPER; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DILATATION; DIABETES MELLITUS; HEART LEFT VENTRICLE FUNCTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MENOPAUSE; MICROCIRCULATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

CORONARY ANGIOGRAPHY; CORONARY VESSELS; DIABETES MELLITUS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; MENOPAUSE; SMOKING;

EID: 0031967361     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (27)

1. Nabel EG, Ganz P, Gordon JB, Alexander RW, Selwyn AP. Dilation of normal and constriction of atherosclerotic coronary arteries caused by the cold presser test. Circulation 1988; 77: 43-52
2. Berliner JA, Navad M, Fogelman AM et al. Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. Circulation 1995; 91: 2488-2496
3. Zelher AM, Fissithaler B, Schray-Utz B, Busse R. Nitric oxide modulates the expression of monocyte chemoattractant protein 1 in cultured human endothelial cells. Circ Res 1995; 76: 980-986
4. Tsao PS, McEvoy LM, Drexler H, Butcher EC, Cooke JP. Enhanced endothelial adhesiveness in hypercholesterolemia is attenuated by L-argmine. Circulation 1994; 89: 2176-2182
5. Vanhoutte PM, Rimele TJ. Role of the endothelium in the control of vascular smooth muscle. J Physiol (Paris) 1983; 78: 681-686
6. Furchgott R, Zawadzki J. The obligatory role of endothelial cells in relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373-376
7. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327: 524-526
8. Nitenberg A, Valensi P, Sachs R, Dali M, Aptecar E, Attali JR. Impairment of coronary vascular reserve and Ach-induced coronary vasodilation in diabetic patients with angiographically normal coronary arteries and normal left ventricular systolic function. Diabetes 1993; 42: 1017-1025
9. Antony I, Aptecar E, Lerebours G, Nitenberg A. Coronary artery constriction caused by the cold presser test in human hypertension. Hypertension 1994; 24: 212-219
10. Antony I, Lerebours G, Nitenberg A. Loss of flow-dependent coronary artery dilation in patients with hypertension. Circulation 1995; 91: 1624-1628
11. Nitenberg A, Antony I, Foult JM. Acetylcholine-induced coronary vasoconstriction in young, heavy smokers with normal coronary arteriographic findings. Am J Med 1993; 95: 71-77
12. Nitenberg A, Antony I, Aptecar E, Arnoult F, Lerebours G. Impairment of flow-dependent coronary dilation in hypertensive patients. Demonstration by cold presser test induced flow velocity increase. Am J Hypertension 1995; 8: 13S-18S
13. Yanagisawa M, Kurihara H, Kimura S et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332: 411-415
14. Calver A, Collier J, Moncada S, Vallance P. Effect of local intra-arterial NG-monomethyl-L-arginine in patients with hypertension: the nitric oxide dilator mechanism appears abnormal. J Hypertension 1992; 10: 1025-1031
15. Rubanyi GM, Romero JC, Vanhoutte PM. Flow-induced release of endothelium relaxing factor. Am J Physiol 1986; 250: H1145-H1149
16. Brush JE, Faxon DP, Salmon S, Jakobs AK, Ryan TJ. Abnormal endothelium-dependent coronary vasomotion in hypertensive patients. J Am Coll Cardiol 1992; 19: 809-815
17. Egan B, Panis R, Hinderliter A, Schork N, Julius S. Mechanism of increase alpha-adrenergic vasoconstriction in human essential hypertension. J Clin Invest 1987; 80: 812-817
18. Schiffrin EL, Thibault G. Plasma endothelin in human essential hypertension. Am J Hypertension 1991; 4: 303-308
19. Rubanyi GM, Vanhoutte PM. Superoxide anions and hyperoxia inactivate endothelium-dependent relaxing factor. Am J Physiol 1986; 250: H822-H827
20. Pieper GM, Gross GJ. Oxygen free radicals abolish endothelium-dependent relaxation in diabetic rat aorta. Am J Physiol 1988; 255: H825-H833
21. Ohara Y, Peterson TE, Harrison DG. Hypercholesterolemia increases endothelial Superoxide anion production. J Clin Invest 1993; 91: 2546-2551
22. Matsuda Y, Hirata K, Inoue N et al. High density lipoprotein reverses inhibitory effect of oxidized low density lipoprotein on endothelium-dependent arterial relaxation. Circ Res 1993; 72: 1103-1109
23. Gilligan DM, Quyyumi AA, Cannon RO. Effects of physiological levels of estrogen on coronary vasomotor function in post-menopausal women. Circulation 1994; 89: 2545-2551
24. Leung WH, Lau CP, Wong CK. Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolemic patients. Lancet 1993; 341: 1496-1500
25. Levine GN, Frei B, Koulouris SN, Gerhard MD, Keaney JF, Jr, Vita JA. Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation 1996; 93: 1107-1113
26. Collins P, Rosano GMC, Sarrel PM et al. 17 β-Estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease. Circulation 1995; 92: 24-30
27. Nitenberg A, Antony I. Epicardial coronary arteries are not adequately sized in hypertensive patients. J Am Coll Cardiol 1996; 27: 115-123